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Abstract
Background: Control of sexually transmitted infections (STIs) is an important part of the effort to reduce the risk of HIV/AIDS.
STI clinics in the government hospitals in India provide services predominantly to the poor. Data on the cost and efficiency of
providing STI services in India are not available to help guide efficient use of public resources for these services.
Methods: Standardised methods were used to obtain detailed cost and output data for the 2003–2004 fiscal year from written
records and interviews in 14 government STI clinics in the Indian state of Andhra Pradesh. The economic cost per patient
receiving STI treatment was calculated, and the variations of total and unit costs across the STI clinics analysed. Multivariate
regression technique was used to estimate incremental unit costs. The optimal number of STIs that could be handled by the
clinics was estimated.
Results: 18807 STIs were diagnosed and treated at the 14 STI clinics in fiscal year 2003–2004 (range 323–2784, median 1199).
The economic cost of treating each STI varied 5-fold from Indian Rupees (INR) 225.5 (US$ 4.91) to INR 1201.5 (US$ 26.15)
between 13 clinics, with one other clinic having a very high cost of INR 2478.5 (US$ 53.94). The average cost per STI treated
for all 14 clinics combined was INR 729.5 (US$ 15.88). Personnel salaries made up 76.2% of the total cost. The number of STIs
treated per doctor full-time equivalent and cost-efficiency for each STI treated had a significant direct non-linear relation (p <
0.001, R2 = 0.81; power function). With a multiple regression model, apart from the fixed costs, the incremental cost for each
STI detected and cost of treatment was INR 55.57 (US$ 1.21) and for each follow-up visit was INR 3.75 (US$ 0.08). Based on
estimates of optimal STI cases that could be handled without compromising quality by each doctor full-time equivalent available,
it was projected that at 8 of the 14 clinics substantially more STI cases could be handled, which could increase the total STI cases
treated at the 14 clinics combined by 38% at an additional cost of only 3.5% for service provision.
Conclusion: There is un-utilised capacity in the public sector STI clinics in this Indian state. Efforts to facilitate utilisation of this
capacity would be useful, as this would enable more poor patients with STIs to be served at minimal additional cost, and would
also reduce the cost per STI treated leading to more efficient use of public resources.
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Background
India has one of the highest number of persons living
with HIV in the world [1,2]. The presence of sexually
transmitted infections other than HIV (referred to as STIs
in this paper) increases substantially the risk of acquiring/
transmitting HIV, and therefore, the control of STIs can be
an important part of the effort to control emerging HIV
epidemics [3]. The state of Andhra Pradesh with 80 mil-
lion population has one of the highest estimated burden
of HIV among the Indian states based on antenatal senti-
nel surveillance, and also one of the highest HIV preva-
lence (16–30%) among public sector STI clinic attendees
included in the sentinel surveillance during 1998–2004
[4].
STI clinics in the public sector hospitals run by the govern-
ment provide care predominantly to the poor segment of
society in India, and therefore, their role in controlling
STIs and HIV is particularly important. Recognising the
important role that the public sector STI clinics could play
in HIV control, the number of formally designated STI
clinics in the government hospitals in Andhra Pradesh
was increased from 28 to 85 in the year 2002 (oral com-
munication, Andhra Pradesh State AIDS Control Society,
Hyderabad, India, 14 December 2004).
With HIV/AIDS control having become a major public
health issue in India [5], the funding available for this has
been increasing [6,7]. However, assessment of the cost
and efficiency of various strategies to control HIV in India
is not readily available [8]. This information is needed for
efficient utilisation of resources available for HIV control.
As part of a study to assess the cost and efficiency of vari-
ous HIV prevention strategies in Andhra Pradesh, we
assessed the cost and efficiency of STI clinics in the public
sector.
Methods
This study was part of a larger multi-country effort to
study cost and efficiency of HIV prevention in India, Mex-
ico, Russia, South Africa and Uganda by the Prevent AIDS
Network for Cost-Effectiveness Analysis (PANCEA) [9].
Details of the methods for the overall multi-country study
are described elsewhere [10]. Description of the methods
relevant for this paper follows. This study was approved
by the Ethics Committee of the Administrative Staff Col-
lege of India, Hyderabad, India and the Committee on
Human Research of the University of California, San Fran-
cisco, USA.
Selection of STI clinics
We included STI clinics in the government-run public sec-
tor hospitals for this study. These clinics provide services
predominantly to the poor at no or minimal fee, and
many persons receiving services here have relatively
advanced STIs. At the time of starting data collection for
this study in mid-2004, 85 public sector clinics were func-
tioning. Of these, 28 STI clinics had been functioning
since the 1960's in the state capital and the district head-
quarters as part of the medical college hospitals and other
major public hospitals of Andhra Pradesh. In addition, 57
STI clinics were formally designated in mid-2002 in pub-
lic hospitals, in district headquarter hospitals and in area
hospitals located in smaller jurisdictions. Generally, the
STI care in medical college hospitals and district head-
quarter hospitals is provided in distinct separate clinics,
whereas in area hospitals it is provided as part of the gen-
eral outpatient.
Andhra Pradesh has three geographic regions: the north-
ern Telangana region has the state capital and nine other
districts, the eastern Coastal region has nine districts, and
the southern Rayalseema region has four districts with a
population of nearly half that in the other two regions. In
order to obtain a broad sample of STI clinics in public
hospitals, we used the three geographic regions of Andhra
Pradesh and the old-new clinics as the two strata for sam-
pling. Fifteen STI clinics were randomly sampled to obtain
six clinics each in the Telangana and Coastal regions and
three clinics in the Rayalseema region, which included
three each of old and new clinics in Telangana and
Coastal regions and two old and one new clinics in Ray-
alseema region.
Data collection procedures
The initial versions of the data collection instruments
from the global PANCEA study were reviewed and
adapted to suit the context of Andhra Pradesh. The data
collection team, consisting of six researchers with back-
ground in economics or finance, was involved with the
adaptation of the instruments and received extensive
training to ensure a standardised approach to data collec-
tion. A pilot study was done to make final refinements in
the data collection format and approach.
Data were collected for the April 2003 – March 2004 fiscal
year at the 15 sampled STI clinics during June – August
2004. Data collection included a history of the evolution
of the STI clinic, detailed cost and output data by month,
and patient exit interviews. Formal informed consent to
collect data was obtained from the senior-most person
responsible for each STI clinic, generally the superintend-
ent of the hospital in which the clinic was located. The STI
clinic medical officer(s), medico-social worker, counsel-
lor, and laboratory technician were interviewed and avail-
able written records reviewed to obtain data. Each visit
started with an interview containing structured open-
ended questions on the history of the STI clinic, and oper-
ational or community factors that may have affected the
demand for or supply of services. Data collection thenBMC Health Services Research 2005, 5:69 http://www.biomedcentral.com/1472-6963/5/69
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proceeded to cost and output data, in parallel with exit
interviews of patients. Data collection at an STI clinic by
three investigators lasted one week. Data were recorded in
the field on laptop computers in MS Excel and MS Word
files, which after review were entered into an MS Access
database.
Cost data
The cost of the STI clinic was divided into five categories:
salaries, recurrent goods, capital goods, recurrent services,
and rentals. These cost data were collected for each
month, as far as possible. Economic cost was computed,
i.e. the true resource cost incurred rather than just the
financial cost. The inpatient cost was also included for the
inpatient facilities that were being utilised for some of the
STI clinic patients. Similar costing methods were used
across the clinics for the five cost categories.
Salary cost was computed for all personnel contributing to
the work of the outpatient and inpatient services of the STI
clinic, which included the medical officer(s), medico-
social worker/counsellor, nurse(s), laboratory technician,
and in some cases attender. If a particular person was con-
tributing part time to the STI clinic work, only that pro-
portion of salary was included in the STI clinic salary cost.
For example, if the medical officer was contributing only
half time to the STI clinic and the other half to teaching
then only half his/her salary was included in the person-
nel cost. The salary of the personnel was noted from the
official records of hospital of which the STI clinic was a
part. If fringe benefits were paid in addition to the regular
salary, these were included.
The major component of recurrent goods was medicines.
The medicines prescribed to patients at these public clin-
ics are provided free. In order to calculate the cost of med-
icines, first the lowest market retail rates of the medicines
usually prescribed at these public clinics for each STI diag-
nosis during the 2003–2004 were obtained. This was dis-
counted by 30%, which is the estimated discount for bulk
purchase of medicines by the government as suggested by
the procurement agency. These rates were then applied to
the number of each type of STI reported by a STI clinic.
The experience of the STI incharge at the Andhra Pradesh
State AIDS Control Society suggested that complicated
cases needed further treatment and that there were varia-
tions in treatment regimens, which would enhanced the
overall medication cost by 25%. Accordingly, this
enhancement was applied to obtain the total medicine
cost for each STI clinic. The other recurrent goods utilised
at the STI clinics included inpatient food expenses, test
kits for STIs, male condoms, behavioural change commu-
nication materials, needles and syringes, gloves, spirit,
sodium hypochlorite solution, cotton, soap, dettol, phe-
nyl, distilled water, test tubes, antigen, blotting paper,
alcohol, liquid paraffin, buffer solution, stationery and
some other laboratory materials and miscellaneous items.
The inpatient food expenses were calculated based on cost
estimates for items on the menu and the number of inpa-
tients. The test kits for STIs were costed by applying 30%
discount to the lowest market rate for bulk purchase by
government, as for the medicines. The market price of the
condoms supplied to the STI clinic is subsidized by 70%
by the government. We considered as the economic cost
of the condom what it would have been without the sub-
sidy. Information was obtained from the Andhra Pradesh
State AIDS Control Society about the cost of the behav-
ioural change communication materials supplied to the
STI clinic, which was used for our analysis. Attempts were
made to get the cost of the other goods from the STI clinic
records, which if available were used for analysis. If not
available, three quotations for these goods were obtained
from the market for the 2003–2004 fiscal year and the
average of these taken as the cost.
Capital goods used for the work of STI clinics included
outpatient and inpatient furniture, electrical fixtures,
refrigerator, centrifuge, microscope, needle and syringe
destroyer, water bath, slide rotator, water filter, sterilizer,
and weighing machine. As for recurrent goods, if informa-
tion about the cost of capital goods was not available from
the STI clinic or its parent hospital, the market price was
determined from retail sellers of these goods. The life of
the capital goods was assumed to be five years, and there-
fore, one-fifth of the cost was allocated to the 2003–2004
fiscal year if the good was used for the full year. If a good
was purchased in the middle of this fiscal year and used
only for half the year, the cost allocated to this good was
half of the yearly cost. If a capital good, for example refrig-
erator or centrifuge, was also being used for work other
than that of the STI clinic, a determination was made from
the STI clinic staff about the proportion of use for STI
work and that proportional cost was allocated to the STI
clinic.
Recurrent services included cleaning and building mainte-
nance, electricity, water, telephone, gas/oil, waste dis-
posal, the occasional training of staff during that fiscal
year, and some miscellaneous items. The cost of building
maintenance was calculated based on the space occupied
by the outpatient and inpatient components of the STI
clinic. Electricity and water costs were based on applying
the market rates to the estimated usage. The estimated
usage of electricity was calculated from the electrical fix-
tures and the number of hours of use per day and for water
from the daily estimated use by clinic staff and patients.
Telephone and other recurrent services costs were calcu-
lated based on actual expenditure.BMC Health Services Research 2005, 5:69 http://www.biomedcentral.com/1472-6963/5/69
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All STI clinics were located in a parent public hospital, and
no rent was being paid. In order to calculate economic
rental cost, the actual floor area occupied by the outpa-
tient and inpatient services of the STI clinic was deter-
mined, rent rates obtained from three sources in that area
for health facilities for the 2003–2004 period, and the
average of these rates applied to this area.
For area hospitals, where STI care is generally provided as
part of the general outpatient, the costs for STI care were
calculated based on estimates of the proportion of person-
nel time, goods, and services used for STI care, and the
rental cost was apportioned based on the ratio of STI cases
to all outpatient cases. This estimation did not pose sub-
stantial difficulties.
The average exchange rate of Indian Rupees (INR) 45.95
to a US$ for the 2003–2004 fiscal year was used to convert
the INR cost to US$ [11].
Output data
Detailed data were obtained from the written monthly
summary records of the STI clinics regarding the services
provided every month. These included the number and
type of STIs detected and treated, total patient visits, type
of tests done, treatment given for STIs, and number of
patients receiving inpatient services for STIs and inpatient
days. For area hospitals, where STI care is generally pro-
vided as part of the general outpatient, data on visits
related to STIs were taken from the outpatient records that
specify the diagnoses for the visits. Characteristics of pro-
gramme operation were ascertained, including client char-
acteristics and whether there were any hurdles to the
provision of services.
At each STI clinic, 20 patients using the STI services were
interviewed regarding their perceptions about these serv-
ices. The first patients available to the investigators at the
STI clinic during the week of data collection were selected
for interview, after obtaining verbal informed consent that
explained the purpose of the interview and assured ano-
nymity of the respondent. The interviews were conducted
in a quiet corner out of the hearing range of others in
order to encourage honest responses.
Quality control
Quality control measures included a thorough pilot study
before commencing formal data collection, comprehen-
sive training of a qualified data collection team including
their conceptual understanding of all data issues, full
back-up and justification for any data recorded, supervi-
sion of data collection at each STI clinic by the project
Table 1: Number of STIs treated at STI clinics in the fiscal year 2003–2004.
STI clinic STIs diagnosed and treated Total visits Ratio of total 
visits to STIs 
treated
Total number Male Female
Number Percent Number Percent
Medical college hospitals
MC1 2784 1827 65.6 957 34.4 9093 3.27
MC2 1078 792 73.5 286 26.5 7260 6.73
MC3 1921 1189 61.9 732 38.1 7204 3.75
MC4 2186 1514 69.3 672 30.7 7064 3.23
MC5 1743 1333 76.5 410 23.5 4638 2.66
MC6 2223 1255 56.5 968 43.5 4543 2.04
All MC 11935 7910 66.3 4025 33.7 39802 3.33
District headquarter hospitals
DHQ1 1759 851 48.4 908 51.6 2058 1.17
DHQ2 1320 788 59.7 532 40.3 1365 1.03
DHQ3 1012 447 44.2 565 55.8 1530 1.51
DHQ4 323 257 79.6 66 20.4 1220 3.78
A l l  D H Q 4 4 1 4 2 3 4 35 3 . 1 2 0 7 14 6 . 9 6 1 7 31 . 4 0
Area hospitals
AH1 551 76 13.8 475 86.2 650 1.18
AH2 582 253 43.5 329 56.5 1215 2.09
AH3 558 220 39.4 338 60.6 631 1.13
AH4 767 331 43.2 436 56.8 1842 2.40
All AH 2458 880 35.8 1578 64.2 4338 1.76
Total 18807 11133 59.2 7674 40.8 50313 2.68BMC Health Services Research 2005, 5:69 http://www.biomedcentral.com/1472-6963/5/69
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coordinator, thorough review by the study team of the
data obtained at each STI clinic, and contacting the STI
clinics again to obtain information about data issues that
needed clarification after the review.
Data analysis
Analysis of the data was done using SPSS statistical soft-
ware. The average economic cost per patient diagnosed
and treated for STI was calculated as the measure of cost-
efficiency of each STI clinic. The relation of this measure
of efficiency with the cost components was assessed
through regression analyses. Incremental costs for initial
and follow-up visits were assessed using a multiple regres-
sion model. The personnel, capital goods and rental costs
were relatively fixed for each STI clinic irrespective of the
volume of services provided. We therefore treated these as
relatively fixed costs, and treated the recurrent goods and
recurrent services as variable costs for each clinic. In addi-
tion to using the number of initial and follow-up visits as
independent variables for each STI clinic, we also used the
fixed costs as a variable in the right side of the equation as
the constant alone may not estimate the entire fixed costs
[12]. We used this regression model to assess the total cost
function. A high R2 value would be expected for this
model, since the left side of the equation (total cost) was
determined in our costing largely based on information
present in the right side of the equation. That is, fixed
costs are clinic-specific and a major portion of variable
costs (medicines) was calculated assuming standard
inputs and costs per visit across clinics. This is consistent
with the objective of our model, which was to determine
the incremental costs for initial and follow-up visits.
The optimal number of patients that could have STI
detected and treated in a year was calculated using the fol-
lowing assumptions, which were based on input of STI
clinic staff and persons familiar with the working of these
STI clinics:
1. The number of STIs detected and treated depended
mainly on the availability of full-time equivalents of the
doctor in the outpatient of the STI clinic. Since the major-
ity of the patients attending these clinics have STIs, the
proportion of initial visits not related to STIs is small.
Therefore, the latter would not have a substantial impact
on the number of STIs that could be detected and treated
per full-time equivalent of doctor.
2. An average of two follow-up visits for each STI, i.e. a
total of three visits for each STI diagnosis, would be useful
for quality care for patients attending these clinics.
3. During the usual 5 working hours of the STI clinic out-
patient in a day, a doctor could satisfactorily see 5 patients
with new STI diagnosis and 10 follow-ups, without com-
promising quality.
4. Considering 250 working days in a year, for each doctor
full-time equivalent available in the outpatient clinic,
1250 new STIs could be diagnosed and treated without
compromising quality.
The economic cost for providing services to the optimal
number of STI patients was then estimated.
Reliable data on the number of STIs detected and treated
at one of the sampled STI clinics located in an area hospi-
tal could not be obtained. Therefore, this clinic was
excluded from the analysis and data are presented for 14
of the 15 sampled STI clinics.
Results
A total of 18807 diagnoses and associated treatment for
STIs were reported by the 14 STI clinics in the 2003–2004
fiscal year, with a median value of 1199 and mean of 1343
(Table 1). This number was generally highest at STI clinics
located in the tertiary hospitals of medical colleges, fol-
lowed by the STI clinics in district headquarter hospitals,
and least in the STI clinics in area hospitals. This trend was
largely due to the differences in the relative sizes of the
catchment populations for these three categories. Of the
total STIs detected and treated, 59.2% were in males. The
male to female ratio was highest at 3:2 for medical college
hospital STI clinics but was reverse in area hospital STI
clinics (Table 1). The ratio of total out-patient visits to the
cases of STIs detected and treated was reported to be high-
est by the medical college hospital STI clinics (3.33) as
compared with the district headquarter hospital STI clin-
ics (1.40) and for the area hospital STI clinics (1.76), sug-
gesting that the number of follow-up visits is relatively
Table 2: Distribution of reported STI diagnoses.
No. Type of STI Number Percent
1 Herpes 2507 13.3
2 Chlamydial infection 2212 11.8
3 Gonorrhea 1389 7.4
4 Nonspecific genital ulcer 1249 6.6
5 Nonspecific vaginal discharge 1139 6.1
6 Candidiasis 1123 6.0
7 Syphilis 1007 5.4
8 Genital warts 808 4.3
9 Trichomonas 643 3.4
10 Chancroid 586 3.1
11 Lymphogranuloma venereum 228 1.2
12 Bacterial vaginosis 225 1.2
13 Donovanosis 160 0.9
14 Miscellaneous including scabies and 
pediculosis
5532 29.4
Total 18807 100BMC Health Services Research 2005, 5:69 http://www.biomedcentral.com/1472-6963/5/69
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higher in the medical college STI clinics. Data regarding
the exact reason for each visit were not available. How-
ever, it is estimated that the majority of the initial visits in
these clinics result in STI diagnoses, and the majority of
other visits are follow-up visits related to STI treatment
and counselling.
All sampled medical college hospitals and most district
headquarters hospitals had specialist(s) trained in STIs
available for outpatients in their STI clinics, whereas most
area hospitals did not have a specialist for their STI clinics.
The diagnosis of STIs was most frequently made based on
clinical assessment without complete laboratory investi-
gations. Investigations were done most often in STI clinics
in medical college hospitals, infrequently in district head-
quarter hospitals, and almost never in area hospitals. The
diagnoses of STIs reported by these STI clinics are shown
in Table 2. Of the classic STIs, the diagnosis of herpes was
reported to be the highest. Considering all diagnoses
together, the highest reported diagnosis was the miscella-
neous category that included mostly scabies and some
pediculosis and others.
The total economic cost of services provided by the 14 STI
clinics during the 2003–2004 fiscal year was INR
13,719,992 (US$ 298,585), of which 9.9% was for inpa-
tient services provided for 1106 (5.9%) of the total 18807
STIs treated. Of the total cost, personnel made up 76.2%,
recurrent goods 10.2% (58.5% of this was for STI medi-
cines), rentals 9.9%, recurrent services 2.1%, and capital
goods 1.7%. There were modest variations in these pro-
portional costs among some of the STI clinics (Table 3). If
the financial costs were considered, by excluding the costs
for rentals and condom subsidy, these would be 10.4%
less than the economic costs for the 14 STI clinics com-
bined.
The economic cost for each patient detected to have STI
and treated for it varied 5-fold between 13 of the 14 STI
clinics from INR 225.5 (US$ 4.91) to INR 1201.5 (US$
26.15), with a median of INR 609.9 (US$ 13.27) (Table
3). The remaining STI clinic had an unusually high cost
per STI detected and treated (INR 2478.5, US$ 53.94). The
average cost of detecting and treating each STI for patients
at all the 14 STI clinics combined was INR 729.5 (US$
Relationship between STIs treated per doctor full-time equivalent and the cost per STI treated (p < 0.001, power function).  FTE is full-time equivalent, INR is Indian Rupee Figure 1
Relationship between STIs treated per doctor full-time equivalent and the cost per STI treated (p < 0.001, power function). 
FTE is full-time equivalent, INR is Indian Rupee.
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Table 3: Economic cost of STI clinics in the 2003–2004 fiscal year.
STI clinic* Total economic cost Percent of economic cost Percent cost due to 
inpatient services†
Number of 
STIs treated
Cost per STI treated
INR US$ Personnel Recurrent 
goods
Rentals Recurrent 
services
Capital 
goods
INR US$
Medical college hospitals
MC6 1283694 27937 76.5 12.2 6.2 2.7 2.4 8.3 2223 577.5 12.6
MC5 1345786 29288 82.7 7.4 6.7 1.7 1.6 2.6 1743 772.1 16.8
MC4 1746668 38012 75.0 10.0 11.3 1.8 1.9 9.8 2186 799.0 17.4
MC3 1569840 34164 80.6 9.7 6.0 2.0 1.7 5.3 1921 817.2 17.8
MC2 1061341 23098 66.8 8.8 19.2 3.0 2.1 10.2 1078 984.5 21.4
MC1 3345020 72797 79.8 8.0 9.9 1.2 1.1 17.2 2784 1201.5 26.1
All MC 10352349 225296 77.7 9.1 9.6 1.9 1.6 10.4 11935 867.4 18.9
District headquarter hospitals
DHQ1 396627 8632 63.9 25.3 6.4 2.9 1.4 11.0 1759 225.5 4.9
DHQ2 349816 7613 62.5 22.7 8.2 3.4 3.3 15.0 1320 265.0 5.8
DHQ3 612111 13321 73.2 9.8 14.1 1.8 1.1 9.1 1012 604.9 13.2
DHQ4 800543 17422 75.3 4.9 16.7 1.8 1.3 5.2 323 2478.5 53.9
All DHQ 2159097 46988 70.5 12.9 12.7 2.2 1.6 9.0 4414 489.1 10.6
Area hospitals
AH2 198736 4325 60.2 18.4 11.9 5.9 3.6 14.2 582 341.5 7.4
AH4 329889 7179 71.5 14.4 9.0 2.8 2.2 9.7 767 430.1 9.4
AH3 340348 7407 78.7 11.2 5.4 3.0 1.7 6.2 558 609.9 13.3
AH1 339572 7390 76.0 14.2 5.0 3.0 1.7 0.6 551 616.3 13.4
All AH 1208545 26301 72.9 14.1 7.4 3.4 2.2 6.9 2458 491.7 10.7
Total 13719992 298585 76.2 10.2 9.9 2.1 1.7 9.9 18807 729.5 15.9
INR is Indian Rupee
1 US$ = INR 45.95 (average exchange rate in the 2003–2004 fiscal year) [11]
*STI clinics arranged within each hospital type category in decreasing order of cost-efficiency, i.e. increasing order of cost per STI treated.
†This inpatient cost does not include cost of medicines for treatment of STIs, which would have been incurred even if these patients were treated as outpatient.BMC Health Services Research 2005, 5:69 http://www.biomedcentral.com/1472-6963/5/69
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15.88). The average cost of detecting and treating each STI
was 77% higher at the STI clinics in the medical colleges
compared with those at district headquarter and area hos-
pitals (Table 3).
Since personnel accounted for the major portion of cost,
and doctors had the highest relative salary among person-
nel, there was a significant direct non-linear relation
between the number of STI cases treated per doctor full-
time equivalent in a year and the cost-efficiency for each
STI case treated at the 14 STI clinics, the best fit for which
was obtained with a power function (p < 0.001, R2 = 0.81)
as shown in Figure 1. If data for the one clinic with an
exceptionally high cost per STI treated were excluded
(DHQ4), considering it as an outlier, the best fit for this
relation was obtained with an exponential function (p <
0.001, R2 = 0.81) as shown in Figure 2.
Considering the 2003–2004 fiscal year data from each STI
clinic as a data point, the multiple regression model
explained in the methods section was used to assess total
economic cost as a function of fixed costs, cost of initial
visits in which STI cases were detected (including treat-
ment cost), and cost of other visits (mostly follow-up vis-
its), which revealed the following relation:
 = 3036.35 + 1.04 X + 55.57 Y + 3.75 Z
where   is total economic cost in INR, X is fixed costs, Y
is the number of initial visits in which STI cases were
detected and treatment/medicines given, and Z is the
number of other visits. As expected, this model had a high
R2 value of almost 1.00. The fit of the model was signifi-
cant at p <0.001 (F = 15906; degrees of freedom: 3 for
regression, 10 for residual, 13 total). In this model, two
variables (fixed costs and initial visits) were statistically
significant whereas one variable (follow-up visits) was not
(Table 4). This model suggests that apart from the con-
stant/fixed costs, the additional cost for each initial visit in
which STI was detected and treatment given (including
cost of treatment) was INR 55.57 (US$ 1.21) and the
additional cost for each follow-up visit was very small at
INR 3.75 (US$ 0.08).
Personnel at 13 of the 14 (92.9%) STI clinics responded
that more patients could be served by their STI clinics with
the available personnel and infrastructure if there were
more demand. Based on the assumptions mentioned in
the methods section about the number of STI cases that
could be detected and treated without compromising
quality by each doctor in a year if there were optimal
demand, 4 of the 6 medical college STI clinics, 2 of the 4
district headquarter STI clinics, and 2 of the 4 area hospi-
tal STI clinics could increase the number of STIs detected
and treated per year substantially by 54–287% with the
available personnel and infrastructure (Table 5). If this
were achieved, the overall number of STI cases detected
and treated by the 14 STI clinics could increase by 38%
from 18807 to 25916. The total cost for this would
increase only by 3.5% from the 2003–2004 cost of INR
13,719,992 (US$ 298,585) to INR 14,203,222 (US$
309,102), using the equation   = 3036.35 + 1.04 X +
55.57 Y + 3.75 Z from the multiple regression model men-
tioned previously for incremental costs.
In addition to inadequate demand as the major hurdle to
provision of services, two STI clinics mentioned inade-
quate supplies and two clinics mentioned inadequate
staffing as hurdles. The two clinics that mentioned inade-
quate supplies as hurdle (AH1 and AH3) had the highest
cost per STI treated among the area hospitals (Table 3) but
this was close to the median cost per STI treated for all
clinics considered together. One of the clinics that men-
tioned inadequate staffing as hurdle (DHQ4) had the
highest cost of all per STI treated and the other (AH2) had
one of the lowest costs of all per STI treated (Table 3). The
small proportion of clinics reporting hurdles other than
inadequate demand prevent generalisations about the
relation of these hurdles to efficiency.
The proportion of full-time equivalents for female doctors
available in the STI clinics of medical colleges was much
lower than in the STI clinics of district headquarters and
area hospitals (Table 5), which would partly be responsi-
ble for the relatively lower proportion of female patients
treated in the medical college STI clinics (Table 1).
The patient interviews at the STI clinics revealed 70.4%
were very satisfied with the services provided, and the
remaining were somewhat satisfied, with no one men-
tioning that he/she was not satisfied (Table 6).
All medical college hospital STI clinics and two district
headquarter STI clinics (DHQ2 and DHQ4) were old STI
clinics (established since 1960s), and the remaining were
newly designated STI clinics in 2002. Because major dif-
ferences in the services and cost-efficiency were observed
between STI clinics located in the three categories of hos-
pitals, and the only category that had both old and new
clinics was the district headquarter hospitals, separate
analysis for old and new clinics was not done.
Discussion
In the Andhra Pradesh state of India, analysis of 14 public
sector STI clinics revealed that the average cost of diagnos-
ing and treating each STI was INR 729.5 (US$ 15.88), and
this cost ranged many-fold between the 14 clinics. Fixed
costs of the STI clinics made up the predominant propor-
tion, with personnel costs exceeding three-fourths of the
total cost. Although it is unusual to think of personnel as
ˆ C
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fixed costs, this concept applies here as the personnel were
employed at the STI clinics regardless of the amount of
services delivered. Based on estimates of optimal work-
load that could be handled by the available personnel, we
estimated that a large proportion of these STI clinics could
deal with more STI cases without compromising quality,
which would increase the number of STIs treated at the 14
clinics by over one-third the number treated in the 2003–
2004 fiscal year at a minimal additional cost of about
3.5% for provision of services. This does not include the
additional costs that may be involved in increasing the
demand for these services. These are difficult to assess and
need to be assessed over a period of time, and may or may
not be large. Since the public sector STI clinics predomi-
nantly serve poor patients in India at almost no direct cost
to the patients, it is important that mechanisms be devel-
oped to utilise the unused capacity in these clinics. This
would result in more poor patients to be served and more
efficient use of the public resources available for STI and
HIV control.
Substantial differences were found in the services and
cost-efficiency between the STI clinics at the three differ-
ent type of locations, i.e. medical college, district head-
quarter and area hospitals. The number of STIs treated per
full-time doctor equivalent, as well as the cost-efficiency
per STI treated, was least in the medical college hospital
STI clinics. However, it is important to note that medical
college clinics also had the highest number of follow-up
visits per STI, availability of STI specialists, and level of
investigations for diagnosis, suggesting that the thorough-
ness of STI care would be higher at these clinics. In addi-
tion, the tertiary medical college clinics are estimated to
get more complicated patients and also serve a vital role
in the teaching of residents and medical students. There-
fore, the relatively higher cost per STI treated in medical
college clinics is by itself not a negative thing, if it is asso-
ciated with provision of higher quality care and care to
more complicated patients. Attempts at improving cost-
efficiency should not be at the expense of quality of care.
We calculated the optimal workload that could be han-
dled by the personnel at the STI clinics taking into account
the need to maintain quality. The highest relative unused
capacity was in the medical college hospital STI clinics.
On the other hand, the low number of follow-up visits at
the district headquarter and area hospital STI clinics sug-
gests that emphasis on encouraging follow-ups and qual-
ity of care is needed. In addition, the exceptionally high
number of STI patients treated at two district headquarter
hospital STI clinics (DHQ1 and DHQ2) and the high
Relationship between STIs treated per doctor full-time equivalent and the cost per STI treated after excluding one extreme  value that could be considered an outlier (p < 0.001, exponential function). FTE is full-time equivalent, INR is Indian Rupee Figure 2
Relationship between STIs treated per doctor full-time equivalent and the cost per STI treated after excluding one extreme 
value that could be considered an outlier (p < 0.001, exponential function). FTE is full-time equivalent, INR is Indian Rupee.
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number at one area hospital STI clinic (AH2) per full-time
doctor equivalent available suggests that the need for
ensuring quality of care must be emphasised, assuming
that quality is impaired by an excessive caseload.
The relatively low proportion of female patients treated at
medical college hospital STI clinics can perhaps be attrib-
uted to the lower proportion of female doctors available
at these clinics as compared with district headquarter and
area hospital STI clinics, and also to the fact that gynaecol-
ogy clinics are available at medical college hospitals that
are usually staffed by female doctors and many females go
to these clinics for STI-related symptoms. Another factor
for the relatively higher proportion of female STI patients
seen at the area hospitals is the fact that the STI clinics in
these hospitals run as part of the general outpatient and
not as a distinctly separate clinic, which encourages more
females to utilise these services.
Inpatient services are used by the STI clinics to admit
patients of very advanced STIs who are quite poor and
have a low chance of coming back for follow-up.
Although these inpatient services make up 10% of the
total cost for 6% of the total STIs treated, this is generally
utilised for the STI patients who are most in need and who
are at high risk of not completing the treatment and fol-
low-up in the absence of these services, and therefore, may
be justified.
The reported distribution of STI diagnoses should be
interpreted cautiously in the background that investiga-
tions are done almost never at area hospital clinics and
infrequently at district headquarter hospital clinics, and
that STI specialists are mostly not available at area hospi-
tal clinics. The very high proportion of scabies reported by
these public sector STI clinics is generally suggestive of the
very low socioeconomic status of the patients utilising the
services of these clinics.
An encouraging finding in this study was that of the
patients interviewed at the STI clinics over two-third were
very satisfied with the clinic services and the remaining
somewhat satisfied, with no respondent reporting dissat-
isfaction. This implies that once the patients, who are
mostly poor, reach the STI clinic and use its services, they
are generally satisfied with the services. An important fac-
tor in this perception is likely to be the fact that free med-
icines are given for treatment.
Consideration of the above mentioned issues would have
to be kept in mind while planning methods to enhance
utilisation of the unused capacity in the public sector STI
clinics in this Indian state such that the quality of services
is also adequate. One major issue that comes in the way of
more demand for services of these clinics is the stigma that
is attached with attending an STI clinic, which is com-
monly perceived by the society to be associated with poor
personal character or other negative attributes. An option
that could be explored to reduce this stigma would be to
give a more innocuous name to these clinics, such as, fam-
ily health clinics, and provide STI services as part of a com-
prehensive sexual health package. Such an approach
would require some restructuring, but may be worth con-
sidering as a long-term solution for better utilisation of
STI services in the public sector hospitals. Another issue
that needs to be addressed to increase the utilisation of
services at public sector STI clinics is the development of
systematic linkages with non-governmental organisations
working with high-risk groups such as sex workers, such
that they can easily avail the services of these STI clinics.
The majority of outpatient health care in India, including
STI treatment, is provided by the private sector [13]. It is
also widely believed that the patients who use the public
sector STI clinics are predominantly poor and with rela-
tively advanced STIs that have often been unsuccessfully
treated elsewhere. In this background, the cost and effi-
ciency analysis presented in this paper pertains to this
most vulnerable group. The high rate of 16–30% HIV in
the public sector STI clinic attendees who participated in
the sentinel surveillance in Andhra Pradesh over the past
few years [4] supports the interpretation that these
patients are highly vulnerable. It is possible that the cost-
efficiency trends for the private sector STI care in India
may be different from those in the public sector. However,
it may not be unreasonable to assume that the cost-effi-
ciency estimates of public sector STI care apply to those
who are at most risk of acquiring or transmitting HIV, and
Table 4: Coefficients in the multiple regression model and their significance.
Variable Coefficient (βi) Standard error t Significance
Constant 3036.35 8049.64 0.377 0.714
Fixed costs 1.04 0.01 95.761 0.000
Visits in which STI was detected 55.57 8.28 6.712 0.000
Other visits (mostly follow-up) 3.75 2.88 1.300 0.223
Dependent variable: Total costBMC Health Services Research 2005, 5:69 http://www.biomedcentral.com/1472-6963/5/69
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therefore, are important for assessing and comparing the
cost-efficiency and cost-effectiveness of the various HIV
prevention strategies.
Estimates of cost and efficiency of STI services in India,
and their effectiveness in preventing HIV, have not been
previously readily available from India [14]. In fact, the
cost estimates of STI treatment from the Mwanza study in
Tanzania [15] were used previously by the World Bank to
estimate the STI care resources needed in India while pre-
paring the loan agreement for supporting India's AIDS
control programme [16]. The cost-efficiency estimates
presented in this paper could be used to estimate the
resources needed for STI care by the public health care sys-
tem in Andhra Pradesh, and these data also point to some
issues which, if addressed, could lead to enhancement in
the provision of these services and also their cost-effi-
ciency. These cost and efficiency estimates of STI treat-
ment could also be used to estimate cost-effectiveness of
STI treatment for HIV prevention in India either by using
Table 5: Optimal number of STIs that could be treated at the STI clinics.
STI clinic* Doctor full-time equivalents 
available
Number of STIs 
treated in fiscal year 
2003–2004
Optimal number of 
STIs that could be 
treated†
Percent increase if 
optimal number 
treated
Total Male (%) Female (%)
Medical college hospitals
MC6 1.20 1.20
(100)
0
(0)
2223 1500
MC5 1.50 1.25
(83.3)
0.25
(16.7)
1743 1875 8
MC4 3.00 1.50
(50.0)
1.50
(50.0)
2186 3750 72
MC3 2.46 1.96
(79.7)
0.50
(20.3)
1921 3075 60
MC2 1.50 1.50
(100)
0
(0)
1078 1875 74
MC1 5.50 5.00
(90.9)
0.50
(9.1)
2784 6875 147
All MC 15.16 12.41
(81.9)
2.75
(18.1)
11935 18950 59
District headquarter hospitals
DHQ1 0.40 0.40
(100)
0 
(0)
1759 500
DHQ2 0.33 0
(0)
0.33
(100)
1320 413
DHQ3 1.25 0.25
(20.0)
1.00
(80.0)
1012 1563 54
DHQ4 1.00 1.00
(100)
0
(0)
3 2 31 2 5 02 8 7
All DHQ 2.98 1.65
(55.4)
1.33
(44.6)
4414 3725
Area hospitals
AH2 0.20 0.20
(100)
0
(0)
582 250
AH4 0.58 0.33
(56.9)
0.25
(43.1)
767 725
AH3 1.00 0.70
(70.0)
0.30 
(30.0)
5 5 81 2 5 01 2 4
AH1 0.81 0.31
(38.5)
0.50 
(61.5)
551 1016 84
All AH 2.59 1.54 
(59.5)
1.05 
(40.5)
2458 3241 32
Total 20.73 15.60 
(75.3)
5.13
(24.7)
18807 25916 38
*STI clinics arranged within each hospital type category in decreasing order of cost-efficiency, i.e. increasing order of cost per STI treated.
†Based on the assumption that one full-time equivalent doctor could satisfactorily treat 1250 STIs in a year, as described in the methods section.BMC Health Services Research 2005, 5:69 http://www.biomedcentral.com/1472-6963/5/69
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published estimates of effectiveness from other parts of
the world or by conducting studies on effectiveness of STI
treatment in preventing HIV in India. In addition, these
cost-efficiency estimates of STI treatment would be com-
pared with similar estimates from other countries in the
PANCEA study that are using similar methodology [10],
and also with estimates for other HIV prevention strate-
gies in Andhra Pradesh, such as HIV voluntary counselling
and testing [17] and HIV prevention programmes for
female sex workers [18] using similar methodology. Such
standardised cross-country and country-specific cost-effi-
ciency estimates would be very useful in estimating the
resources needed for HIV control in specific countries as
well as globally with more confidence than has been pos-
sible so far with the available data. This is important in the
background of the extensive debate in recent times about
the resources needed to control HIV.
Conclusion
In the Indian state of Andhra Pradesh, there is un-utilised
capacity in the public sector STI clinics that provide serv-
ices predominantly to the poor. Efforts to facilitate utilisa-
tion of this capacity would be useful, as this would enable
more poor patients with STIs to be served at minimal
additional cost, and would also reduce the cost per STI
treated leading to more efficient use of public resources.
Comprehensive and dynamic analysis of the efficiency of
HIV prevention services using standardised methods is
necessary to make optimal use of the increasing resources
that are becoming available for this purpose in India and
other parts of the developing world.
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